SV Atlas
← All founders
Alex Federation

2x founder

Alex Federation

Co-Founder and CEO at Talus Bio - Measuring the regulome. Re-wiring the genome. Therapeutics for 'undruggable' transcription factors.

Co-founderTalus Bio logoTalus Bio· Summer 2021🇺🇸 Seattle, Washington, United States
2020Co-founder· Talus Bio
Founder · since 2008
Company
Talus Bio
Role
Co-Founder, CEO
current
Stage
—
no public source
Raised
—
no public source
Based
Seattle, Washington, United States
current
Founder / co-founder — the company's markEmployee / research role
Source: LinkedIn work history
Profile coverage5 of 7 · missing posts, contact
Talus Bio logo
Talus Bio

Discovering drugs that target the DNA regulome

Summer 2021

Experience

Career

  • Talus Bio logo

    Talus Bio

    Co-founder

    Co-Founder, CEO · Seattle, Washington, United States · 2020 – Present

    2020
  • SEngine Precision Medicine

    Lead Bioinformatics Scientist & Pharma Alliance Manager · Seattle, Washington, United States · 2020

    2020
  • Navigating Cancer logo

    Navigating Cancer

    Senior Data Scientist · Greater Seattle Area · 2019 – 2020

    2019
  • Altius Institute for Biomedical Sciences

    Research Fellow · 2016 – 2019

    2016
  • Harvard University logo

    Harvard University

    PhD Candidate in Chemical Biology · 2011 – 2015

    2011
  • University of Rochester logo

    University of Rochester

    Teaching Assistant and Tutor · 2008 – 2011

    2008
  • University of Rochester - Department of Chemistry logo

    University of Rochester - Department of Chemistry

    Chemical Biology Research · 2008 – 2011

    2008
  • University of Rochester Summer Research Experience

    Founder

    Founder and Director · 2008 – 2011

    2008
  • Johns Hopkins University logo

    Johns Hopkins University

    REU Fellow - Institute for NanoBiotechnology · 2009

    2009

Bio

I'm the co-founder of Talus Bio. Prior to Talus, I trained with Jay Bradner at Harvard in medicinal chemistry, drug screening, and drug development for gene regulators. After that, I moved to Seattle to continue my training in epigenomics and proteomics, and these were all combined to develop the Talus gene regulator platform.